Ductal Breast Carcinoma in Situ Clinical Trial
Official title:
Diet, Exercise and Estrogen Metabolites Study (DEEM)
This randomized clinical trial studies a group-based lifestyle intervention or usual care in measuring biomarker levels in participants at high risk for breast cancer. Studying the effects that changes to daily eating and exercise habits can have on the body's hormone levels and the body's ability to activate proteins may help doctors identify interventions for individuals at high risk for breast cancer.
PRIMARY OBJECTIVES:
I. To calculate eligibility rates, participation rates, retention, and adherence within the
Diet, Exercise and Estrogen Metabolites (DEEM) study.
II. To determine inter- and intra-person variability of the estrogen-deoxyribonucleic acid
(DNA) adducts (EDA) biomarkers in participants of the DFS.
III. To explore the effects of the intervention on percent adiposity and the EDA ratio at
the end of the 3-month intervention and 6-month follow-up.
SECONDARY OBJECTIVES:
I. To explore the effects of the intervention on the DNA damage repair (DDR) biomarker at
3-months.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants take part in weekly 2-hour group counseling sessions for 6 months with
taper beginning at 3 months. Group sessions include education, group process, and
experiential learning on the benefits of physical activity, balanced nutrition, and
mindfulness techniques. Participants set goals for changing their dietary habits with the
help of a mental health counselor and are also encouraged to exercise 3-4 times per week,
including experiential group activities such as brisk walking, yoga, Zumba, and group
fitness.
ARM II: Participants receive their usual care and are also provided with study materials on
healthy diet and exercise at the end of the study.
After completion of study, participants are followed up for 3 months.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02314156 -
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
|
Phase 2 | |
Active, not recruiting |
NCT01905046 -
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
|
Phase 3 | |
Completed |
NCT01869764 -
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
|
Phase 2 | |
Completed |
NCT02587663 -
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
|
N/A | |
Active, not recruiting |
NCT04537312 -
Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM)
|
N/A | |
Active, not recruiting |
NCT01245712 -
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer
|
Phase 2 | |
Recruiting |
NCT02993159 -
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
|
Phase 2 | |
Completed |
NCT01753908 -
Broccoli Sprout Extract in Treating Patients With Breast Cancer
|
Early Phase 1 | |
Terminated |
NCT02023008 -
Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy
|
N/A | |
Completed |
NCT01849250 -
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
|
Phase 2 | |
Terminated |
NCT01754519 -
Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery
|
Phase 2 | |
Completed |
NCT01819233 -
Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy
|
N/A | |
Active, not recruiting |
NCT03077841 -
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT02352883 -
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
|
N/A | |
Recruiting |
NCT03909282 -
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
|
N/A | |
Completed |
NCT01723943 -
Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients
|
N/A | |
Completed |
NCT00637481 -
A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
|
Phase 1 | |
Completed |
NCT01975363 -
Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03391388 -
3D-CRT, Proton, or Brachytherapy APBI in Treating Patients With Invasive and Non-invasive Breast Cancer
|
Phase 2 | |
Completed |
NCT02526498 -
Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery
|
Phase 2 |